BEIJING KAWIN TECH SHARE HOLDING CO LTD has a total of 11 patent applications. Its first patent ever was published in 2016. It filed its patents most often in China and Republic of Korea. Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are FERRONE SOLDANO, IMMULOGIC PHARMA CORP and ONCOMATRYX BIOPHARMA S L.
# | Country | Total Patents | |
---|---|---|---|
#1 | China | 10 | |
#2 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry | |
#4 | Measurement | |
#5 | Packaging and shipping |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Peptides | |
#4 | Microorganisms | |
#5 | Special acyclic compounds | |
#6 | Steroids | |
#7 | Containers for goods storage | |
#8 | Heterocyclic compounds | |
#9 | Analysing materials | |
#10 | Organic chemistry methods |
# | Name | Total Patents |
---|---|---|
#1 | Yang Jian | 4 |
#2 | Li Xiang | 4 |
#3 | Xu Zheng | 4 |
#4 | Xiong Guoyu | 3 |
#5 | Li Feng | 2 |
#6 | Zhou Desheng | 2 |
#7 | Shi Jifeng | 2 |
#8 | Yan Fukun | 2 |
#9 | Pan Hai | 2 |
#10 | Song Rui | 2 |
Publication | Filing date | Title |
---|---|---|
CN111704669A | anti-CLDN 18 fully humanized antibody for treating advanced gastric cancer | |
CN111808194A | Humanized antibody for treating cancer by combining claudin | |
CN110960486A | Methylnaltrexone bromide injection composition | |
CN110964061A | Refining method of fosfluconazole for injection | |
CN109212220A | Antibody of HCV Rapid detection test strip | |
CN108904496A | For treating the pharmaceutical composition of hepatitis C infection | |
CN108675998A | A kind of crystallinity methyl carbamate class compound | |
KR20200116967A | IL-4Rα antibody and uses thereof | |
CN110105451A | IL-4R Alpha antibodies and application thereof | |
CN107868105A | A kind of preparation method of Suo Feibuwei key intermediates | |
CN107400154A | One kind prepares 3 α, the method for the 7 α-α of bis-hydroxy-6-β of ethyl-5-cholanic acid |